Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ALPL | P05186 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | CLK1 | P49759 | 1/20 | 0.43 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6794161 | 0.88 | CCNA2 (0.50) | KMT2AKDM4EALPLHSD17B10MEN1 | |
| SCHEMBL6787955 | 0.83 | AURKA (0.48) | KMT2AKDM4EHSD17B10CCNA2CDK2 | |
| Hydrochloric Acid SCHEMBL6787558 | 0.76 | CCNA2 (0.42) | KMT2AKDM4EALPLHSD17B10MEN1 | |
| SCHEMBL6791255 | 0.67 | LMNA (0.42) | KMT2AKDM4EALPLHSD17B10MEN1 | |
| Hydrochloric Acid SCHEMBL6792455 | 0.65 | CCNA2 (0.74) | KMT2AKDM4EALPLHSD17B10MEN1 | |
| SCHEMBL6788762 | 0.60 | MEN1 (0.52) | KMT2AKDM4EALPLHSD17B10MEN1 | |
| SCHEMBL856872 | 0.60 | KDM4E (1.00) | KMT2AKDM4EALPLHSD17B10MEN1 | |
| SCHEMBL2614377 | 0.59 | MEN1 (0.71) | KMT2AKDM4EALPLHSD17B10MEN1 | |
| SCHEMBL6794407 | 0.59 | MEN1 (0.61) | KMT2AKDM4EALPLHSD17B10MEN1 | |
| SCHEMBL6793147 | 0.59 | MEN1 (0.56) | KMT2AKDM4EALPLHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040127492-A1 | Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 | PHARMACIA CORPORATION | 2004-07-01 | — | — | US | claimed |
| US-20040127492-A1 | Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 | PHARMACIA CORPORATION | 2004-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040127492-A1 | Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 | MKNK2, MAPKAPK2, MAP3K2 | KMT2A 1257/4885KDM4E 2167/4885ALPL 3297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.